Ocular Oncology and Pathology
短名 | Ocul Oncol Pathol |
Journal Impact | 1.04 |
国际分区 | OPHTHALMOLOGY(Q4) |
ISSN | 2296-4657, 2296-4681 |
h-index | 18 |
涉及主题 | 医学生物遗传学病理内科学外科眼科放射科心理学癌症研究物理化学生物化学免疫学黑色素瘤光学神经科学皮肤病科精神科基因癌症 |
出版信息 | 出版商: S. Karger AG,出版周期: ,期刊类型: journal |
基本数据 | 创刊年份: 2015,原创研究文献占比: 88.24%,自引率:0.00%, Gold OA占比: 5.88% |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Structural Competency for Ocular Oncologists and Pathologists
2024-9-4
Expert Opinions on Uveal Melanoma: Insights from the 58th Ophthalmic Oncology Group Meeting
2024-8-27
Clinical features and initial management outcomes of uveal melanomas in a single tertiary center in Egypt.
2024-8-27
Clinical And Multimodal Imaging Study to Differentiate Amelanotic Choroidal Lesions
2024-8-19
Intraocular Surgery for Retinoblastoma: An Evaluation of Current Evidence
2024-6-24
Erratum
2024-2-20
Sensitivity of Magnetic Resonance Imaging (MRI) in Detection of Choroidal Metastases: A Retrospective Review
2024-2-20
Evidence in Focus: The Sparse Landscape of Randomized Trials on Retinoblastoma Treatment
2024-1-30
Dose-Related Visual Outcomes in the Treatment of Choroidal Melanoma with Stereotactic Radiotherapy
2024-1-1
Retinal pigment epithelial adenoma: Initial treatment outcomes following episcleral brachytherapy
2024-1-1
Neoadjuvant Chemotherapy in Non-Metastatic Eyelid Sebaceous Gland Carcinoma: A Report in 10 Cases
2024-1-1
Description and Characteristics of Ocular Tumor Lysis Syndrome
2024-1-1
Ruthenium-106 Plaque Brachytherapy for Circumscribed Choroidal Hemangioma: A Case Series and Review of Literature
2024-1-1
Jonas Friedenwald, Eugene Wolff, and the Two Books That Helped Bridge the Specialty Gap
2024-1-1
Clinicopathological Correlates of Ocular Surface Squamous Neoplasia
2024-1-1
Adjuvant brachytherapy with ruthenium-106 to reduce the risk of recurrence of conjunctival melanoma after excision
2024-1-1
Is It Possible to Preserve Vision without Compromising Metastases-Free Survival by Use of Fully Fractionated Stereotactic Radiotherapy for Posterior Choroidal Melanoma?
2024-1-1
Belzutifan in Individuals with von Hippel-Lindau Retinal Hemangioblastomas: Institutional Experience and Review of the Literature
2024-1-1
How Much Time Do Focal Treatments for Retinoblastoma Add to Anesthetic Exposure?
2024-1-1
Posterior Uveitis in Ocular-Involving Chronic Lymphocytic Leukemia and the Utility of Negative MYD88 L265P Testing in the Diagnosis
2024-1-1
Clinicopathologic Features of Eyelid Sebaceous Gland Carcinoma Requiring Immunohistochemical Diagnosis
2024-1-1
Subretinal Exudation: The First Presentation of Untreated Choroidal Melanomas
2024-1-1
Retinal focal nodular gliosis have varied clinical courses requiring tailored management: a case series
2024-1-1
Periocular Sebaceous Carcinoma: A Case Audit from the National Specialist Ophthalmic Pathology Service in Liverpool from 2009 to 2022 to Assess the Diagnostic Utility of PRAME Expression
2023-12-10
Ocular Dirofilariasis: A Clinicopathologic Case Series and Literature Review
2023-12-9
MEK Inhibitor-Associated Ocular Hypertension
2023-11-30
Intraocular Invasion by Conjunctival Squamous Cell Carcinoma: Clinical Presentation, Histopathological Findings, and Outcome
2023-11-15
CyberKnife Stereotactic Radiosurgery for Uveal Melanoma: First Case Series in Central America
2023-9-30
Retinoblastoma with MYCN Amplification Diagnosed from Cell-Free DNA in the Aqueous Humor
2023-8-25
Mitogen-Activated Pathway Kinase Inhibitor-Associated Retinopathy: Do Features Differ with Upstream versus Downstream Inhibition?
2023-1-1
Radiation Optic Neuropathy: Management Options
2023-1-1
Orbital Complications and Cost Analysis of Enucleation by Myoconjunctival versus Conventional Techniques for Retinoblastoma
2023-1-1
Sympathetic Ophthalmia in Patients with Enucleation or Evisceration: Pathology Laboratory and IRIS® Registry Experience
2023-1-1
Front & Back Matter
2023-1-1
Front & Back Matter
2023-1-1
Reply to Augsburger et al: Selection Bias May Impact Reported Metastasis Risk for 15-Gene Expression Profile Class 1A/B Patients
2023-1-1
Contents Vol. 9, 2023
2023-1-1
Angiographic Features of Iris Melanocytic Tumors: Nevus versus Melanoma
2023-1-1
Acknowledgement to Reviewers
2023-1-1
Is Tumour Thickness Measurement Required for MOLES Scoring of Melanocytic Choroidal Tumours?
2023-1-1
Edge Creep: Increased Pigmentation at the Border of Choroidal Melanomas Treated with Plaque Brachytherapy
2023-1-1
Predictive Value of the International Classification of Diseases, 9th Revision Codes for Identifying Ocular Oncology Diagnoses
2023-1-1
The 5th Edition of the World Health Organization Classification of Tumours of the Eye and Orbit
2023-1-1
Can Enhancement Pattern in Normal-Sized Optic Nerves on Magnetic Resonance Imaging Better Predict Tumor Invasion in Retinoblastoma Eyes?
2023-1-1
Diffuse Infiltrating Retinoblastoma with Anterior Chamber Involvement: Conservative Management and Identification of RB1 Alterations in Aqueous Humor
2023-1-1
Subconjunctival Ocular Argyrosis following Treatment with Ruthenium 106 Brachytherapy for Choroidal Melanoma
2023-1-1
Outcomes after Proton Beam Irradiation in Patients with Choroidal Melanoma Eligible for Investigational AU-011 Treatment
2023-1-1
Ultrasound Verification of Plaque Brachytherapy Placement in Patients Treated for Primary Uveal Melanoma: A Single-Center Experience
2023-1-1
When Is the Optimum Radiological Response to Proton Beam Therapy in Uveal Melanoma?
2023-1-1
Primary Subretinal Seeding in Retinoblastoma: Clinical Presentation and Treatment Outcomes
2023-1-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远